-
EP4284340
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4284340
| EP4284340 - LIQUID FORMULATION OF PROTEIN AND METHODS OF PREPARING THE SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.11.2023 Database last updated on 30.10.2024 | |
| Former | The international publication has been made Status updated on 05.08.2022 | Most recent event Tooltip | 29.03.2024 | Change: Validation states | published on 01.05.2024 [2024/18] | 29.03.2024 | Change - extension states | published on 01.05.2024 [2024/18] | Applicant(s) | For all designated states Hanmi Pharm. Co., Ltd. 214 Muha-ro Paltan-myeon Hwaseong-si, Gyeonggi-do 18536 / KR | [2023/49] | Inventor(s) | 01 /
LIM, Hyung Kyu Hwaseong-si, Gyeonggi-do 18469 / KR | 02 /
KIM, Sang Yun Hwaseong-si, Gyeonggi-do 18469 / KR | 03 /
HONG, Sung Hee Hwaseong-si, Gyeonggi-do 18469 / KR | [2023/49] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2023/49] | Application number, filing date | 22746230.6 | 26.01.2022 | [2023/49] | WO2022KR01406 | Priority number, date | KR20210011802 | 27.01.2021 Original published format: KR 20210011802 | [2023/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022164204 | Date: | 04.08.2022 | Language: | EN | [2022/31] | Type: | A1 Application with search report | No.: | EP4284340 | Date: | 06.12.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.08.2022 takes the place of the publication of the European patent application. | [2023/49] | Search report(s) | International search report - published on: | KR | 04.08.2022 | Classification | IPC: | A61K9/08, A61K47/12, A61K47/26, A61K47/02, A61K9/00, A61K38/19, A61K47/68 | [2023/49] | CPC: |
A61K9/08 (EP,IL,US);
A61K38/193 (EP,IL,US);
A61K47/02 (EP,IL,US);
A61K47/12 (EP,IL,US);
A61K47/26 (EP,IL,US);
A61K47/60 (EP,IL);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/49] | Title | German: | FLÜSSIGE PROTEINFORMULIERUNG UND VERFAHREN ZUR HERSTELLUNG DAVON | [2023/49] | English: | LIQUID FORMULATION OF PROTEIN AND METHODS OF PREPARING THE SAME | [2023/49] | French: | FORMULATION LIQUIDE DE PROTÉINE ET SES PROCÉDÉS DE PRÉPARATION | [2023/49] | Entry into regional phase | 19.07.2023 | National basic fee paid | 19.07.2023 | Search fee paid | 19.07.2023 | Designation fee(s) paid | 19.07.2023 | Examination fee paid | Examination procedure | 19.07.2023 | Examination requested [2023/49] | 08.03.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 29.01.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]KR20010009171 (HAN MI PHARM IND CO LTD [KR]); | [Y]US2009291062 (FRAUNHOFER WOLFGANG [US], et al); | [XY]KR20110085917 (HANMI HOLDINGS CO LTD [KR]); | [A]KR20150009593 (GENENTECH INC [US]); | [A]KR20160149210 (TAKEDA GMBH [DE]) |